HOT: Two-faced nucleosides combat RNA viruses

Ribavirin is a nucleoside drug used to treat RNA viral infections such as Hepaptitis C, which interferes with RNA metabolism required for viral replication. But its efficiency is relatively low, so in a HOT article just published, Yang He and colleagues at Sichuan University report the synthesis of two new nucleosides and their improved anti-viral activity.

He’s nucelosides contain structural features of two naturally occurring components of RNA (guanine and cytosine). This unique feature allows it to interfere with the RNA virus via hydrogen bond pairing with either guanine or cytosine, as well as allowing it to be recognised by viral enzymes more efficiently than ribavirin.   

 If you want to find out more about these interesting bio-active nucleosides download the article now! It’s free to access until the 18th February.

Synthesis of Janus type nucleoside analogues and their preliminary bioactivity 
Hao-Zhe Yang, Mei-Ying Pan, Da-Wei Jiang and Yang He
Org. Biomol. Chem., 2011, DOI: 10.1039/C0OB00495B

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)